Clinical trial
Multimodal Biomarkers in Coronary Artery Disease Pathogenesis: The Oxford Acute Myocardial Infarction Study (OXAMI Study)
NCT07772570 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multimodal Biomarkers in Coronary Artery Disease Pathogenesis: The Oxford Acute Myocardial Infarction Study (OXAMI Study)
- Lead sponsor
- University of Oxford
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 31, 2012
- Completion date
- December 31, 2046
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis cardiovascular disease, biomarker discovery, cardiac imaging techniques, coronary physiology, genetics, intravascular imaging and microvascular obstruction, myocardial injury, thrombus, trained immunity